Angela Sosa-Molano

Title: Innovations by Angela Sosa-Molano

Introduction

Angela Sosa-Molano is an accomplished inventor based in St. Louis, MO (US). She has made significant contributions to the field of enzyme replacement therapy, particularly in addressing lysosomal storage disorders. With a total of 2 patents, her work is pivotal in advancing medical treatments for rare diseases.

Latest Patents

Angela's latest patents focus on reduced immunogenic proteins for lysosomal storage disorders. These patents disclose methods and compositions for genetically engineered variants of N-acetylgalactosamine-6-sulfatase (GALNS). These variants are designed to be less immunogenic than the wild-type GALNS while maintaining enzymatic activity. This innovation may be used to treat Mucopolysaccharidosis IVA, also known as Morquio A disease (MPS IVA).

Career Highlights

Angela Sosa-Molano is affiliated with Saint Louis University, where she conducts her research and development. Her work has garnered attention for its potential to improve the quality of life for patients suffering from lysosomal storage disorders.

Collaborations

Angela collaborates with Adriana M Montaño-Suarez, who is also a key figure in her research endeavors. Their partnership enhances the innovative capacity of their projects and contributes to the advancement of medical science.

Conclusion

Angela Sosa-Molano's contributions to the field of enzyme replacement therapy are noteworthy. Her innovative approaches to reducing immunogenicity in therapeutic proteins hold promise for treating lysosomal storage disorders. Through her work, she continues to make a significant impact in the medical community.